As of April 24, 2025, Elutia (ELUT) has a market cap of $93.583 million USD. According to our data, Elutia is ranked No.7663 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 24, 2025 | $93.58 M |
-30.04%
|
Dec 31, 2024 | $0.13 B |
73.15%
|
Dec 29, 2023 | $77.26 M |
-49.18%
|
Dec 30, 2022 | $0.15 B |
-32.54%
|
Dec 31, 2021 | $0.23 B |
-53.78%
|
Dec 31, 2020 | $0.49 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Amgen
AMGN
|
$149.68 B |
0.124 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.53 B |
-0.004 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.30 B |
-0.001 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$64.01 B |
1.064 B
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$126.09 B |
0.004 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.26 B |
-0.000 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.88 B |
0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$31.32 B |
-0.001 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.77 B |
-0.000 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.63 B |
-0.000 M
|
![]() USA
|
![]() Incyte
INCY
|
$11.22 B |
-0.000 M
|
![]() USA
|
![]() Illumina
ILMN
|
$12.07 B |
-0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.33 B |
-0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.13 B |
0.000 M
|
![]() USA
|
Market Cap | = | ELUT Stock Price | * | ELUT Shares Outstanding |
= | $2.29 | * | 36.55 M | |
= | $93.58 M |